In summary, we have confirmed the tumor-promoting role of the CCL15-CCR1 axis in ESCC and revealed the downstream AKT/ERK1/2/c-Jun/CDK2 pathway as a key regulatory mechanism. The gene discussed is CDK2; the disease is neoplasm.